STAT+: PBMs warn Trump’s proposal to disclose drug prices is illegal
Stat News • 4/20/2026
Summary
Pharma industry middlemen, known as PBMs, are opposing a proposal by Trump to disclose drug prices. They argue that the proposal is illegal.
Advertisement
Lindy Score Breakdown (V4.2)
4d
Age
1
Sources
from cluster
94
Hours Since Seen
Final Score3/100
CategoryAntiLindy
StatusActive
Recency Multiplier26% (0.5^94/48)
Hero EligibleYes
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 4 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Trump’s boosting of psychedelics, cannabis signal a new era in GOP drug policy
Stat News • Today
STAT+: Pharmalittle: We’re reading about Medicare’s obesity drug pilot, an experimental Roche MS drug, and more
Stat News • 1 day ago
STAT+: With successful trials, Roche takes its MS drug to regulators, but safety questions loom
Stat News • 2 days ago
STAT+: Key GOP senators push back on Trump’s plan to cut NIH, reorganize HHS
Stat News • 2 days ago
STAT+: Legislatures in Colorado and Virginia resist moves to constrain drug affordability boards
Stat News • Today
STAT+: Will bargain-basement telehealth visits help pharma drive drug scripts?
Stat News • 1 day ago
STAT+: At AACR, more strong results for Revolution Medicine’s KRAS drug, plus assurance from NCI’s director
Stat News • 2 days ago
STAT+: From Revolution Medicines, more strong data on KRAS drug and a glimpse of a ‘novel class’ beyond it
Stat News • 2 days ago
STAT+: CMS to ask every state for new audits of health care providers
Stat News • 2 days ago
STAT+: Pharmalittle: We’re reading about a Purdue Pharma settlement, a setback for Merck and Eisai, and more
Stat News • 2 days ago
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 3 weeks ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 4 weeks ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 4 weeks ago
STAT+: Trump budget’s ‘America First’ drug policy proposals
Stat News • 2 weeks ago
STAT+: CMS wants more drugmakers to join Medicaid ‘most-favored nations’ pilot
Stat News • 1+ months
STAT+: RFK Jr. begins his testimony marathon
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about top pharma lobbyist stepping down, genes and GLP-1 drugs, and more
Stat News • 2 weeks ago
STAT+: Pharmalittle: We’re reading about a review of Alzheimer’s drugs, FDA interest in compounded peptides, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about Lilly weight loss pill trial results, slashed U.K. clinical trial times, and more
Stat News • 6 days ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 4 weeks ago